Gilead’s remdesivir now part of India’s Covid treatment protocol, but licences for 5 firms are stuck in red tape - The Indian Express 15-Jun-2020

Gilead’s remdesivir now part of India’s Covid treatment protocol, but licences for 5 firms are stuck in red tape - The Indian Express

It is unclear though how many firms with voluntary licences from Gilead have received the drug regulator’s go-ahead to manufacture and supply remdesivir in India.

More...